Wednesday, 28 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14759
Articles
Company
Drug
Sanofi’s Dupixent Receives FDA Priority Review for COPD Indication Extension
October 21, 2024
Company
Deals
Kexing Pharmaceutical Partners with Yabao to Distribute Generic Nexavar in Ten Countries
February 12, 2025
Policy / Regulatory
Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits
October 21, 2024
Company
Drug
GenScript’s Subsidiary Legend Biotech Gets CHMP Nod for Carvykti Label Expansion in Multiple Myeloma
October 21, 2024
Company
Drug
Celltrion’s Infliximab Biosimilar Shows Promising Long-Term Efficacy and Safety in CD and UC
April 2, 2025
Company
Drug
Takeda’s Recombinant Pig FVIII Drug for Acquired Hemophilia A Approved in China
October 21, 2024
Company
Deals
Mabwell Bioscience Cancels Licensing Agreements with Yangtze River Pharma for Two Drug Candidates
October 21, 2024
Company
Drug
Mabwell Bioscience’s Nectin-4 Targeting ADC Earns FDA Fast-Track Designation for Esophageal Cancer
October 21, 2024
Company
Deals
Boehringer-Ingelheim Partners with CBmed to Accelerate First-in-Class Cancer Medicines Development
October 23, 2025
Company
Drug
Polpharma Biologics’ Biosimilar Candidate PB016 Shows Comparable Profiles to Takeda’s Entyvio
October 22, 2024
Company
Drug
Jiangsu Hengrui Receives NMPA Approval for Adjuvant Therapy Clinical Study of Adebrelimab in NSCLC
October 22, 2024
Company
Drug
BioCity Biopharma Achieves Full Enrollment in Phase II Study of SC0062 for IgA Nephropathy
October 22, 2024
1
2
…
784
785
786
787
788
…
1,229
1,230
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?